Highlander Capital Management LLC Purchases 500 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Highlander Capital Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,940 shares of the healthcare conglomerate’s stock after purchasing an additional 500 shares during the period. UnitedHealth Group accounts for about 6.0% of Highlander Capital Management LLC’s investment portfolio, making the stock its largest position. Highlander Capital Management LLC’s holdings in UnitedHealth Group were worth $12,719,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Outfitter Financial LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Advocacy Wealth Management Services LLC boosted its position in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the last quarter. Tortoise Investment Management LLC lifted its position in UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 23 shares in the last quarter. Finally, Leverty Financial Group LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $34,000. 87.48% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $535.06 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The firm’s 50-day moving average price is $506.46 and its two-hundred day moving average price is $499.44. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The stock has a market capitalization of $500.48 billion, a P/E ratio of 27.94, a P/E/G ratio of 1.65 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter last year, the company posted $4.70 earnings per share. UnitedHealth Group’s revenue was up 12.6% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend was Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s payout ratio is 34.46%.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target on the stock. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Cowen lifted their price objective on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 25th. Royal Bank of Canada set a $563.00 price objective on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Monday, April 18th. Finally, Credit Suisse Group lifted their price objective on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $582.50.

Insider Activity

In other news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the sale, the director now owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John F. Rex sold 13,183 shares of the firm’s stock in a transaction that occurred on Friday, July 29th. The shares were sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the transaction, the chief financial officer now owns 141,508 shares in the company, valued at approximately $76,630,827.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 130,144 shares of company stock valued at $69,269,555. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.